Rapid, Robust LC-MS/MS Analysis of Biomarker Candidates that Show a Correlation to Increase Severity of COVID-19 SymptomsRelease of Method Package for Modified Nucleoside Analysis System Read more
06/28/21 Project Explores LC-MS Data Analytics Methods to Rapidly Characterize Complex Biomolecules NEWS SUMMARY: Waters expands collaboration with Bioprocessing Technology Institute, A*STAR into new areas meant to accelerate bioprocessing and bioinformatics research. Projects include developing analytical workflows for nucleic acid therapeutic products and bioinformatics research to deliver robust and accurate identification for a variety of... Read more
ENSPRYNG is the first and only treatment approved for both adults and adolescents in the EU with AQP4-IgG seropositive NMOSD ENSPRYNG can be used as a monotherapy or in combination with immunosuppressive therapy to reduce relapses and prevent permanent disability In Phase III studies, ENSPRYNG significantly reduced the number and severity of relapses in people... Read more
From May 16 to May 21, 2021, nearly 2,000 young scientists, engineers, entrepreneurs and inventors convened virtually for a week of connecting with their peers and global STEM leaders, events, and $5 million in awards and prizes. The finalists, selected from nearly 400 affiliate fairs in 64 countries, regions and territories, have all completed exemplary... Read more
The authorisation enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalised adult and paediatric patients Basel, 25 June 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19... Read more
06/24/21 MILFORD, Mass.–(BUSINESS WIRE)– Waters Corporation (NYSE: WAT) today announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC and President, Bayer Group Greater China. Dr. Flemming Ornskov, Chairman of the Board, said, “We... Read more
BOSTON – June 24, 2021– Today GE (NYSE: GE) announced the appointment of Peter Arduini as president and Chief Executive Officer of GE Healthcare effective January 3, 2022. Arduini will succeed Kieran Murphy who will continue to serve in his current role until the end of 2021 and then he will serve as a strategic... Read more
Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second quarter... Read more